Loading...
NPI 1578562443 · Providence, RI · Anesthesiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Suchit Aggarwal is a anesthesiology physician provider located in Providence, Rhode Island. This profile covers 12 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Suchit Aggarwal |
| Address | 593 Eddy St |
| City | Providence |
| State | RI |
| ZIP | 02903 |
| Taxonomy | Anesthesiology Physician |
| NPI Enumerated | July 21, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $16.7K |
| Medicaid | $15.9K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
12 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 01402 | The provider performs anesthesia services for a patient undergoing an open or arthroscopic total knee arthroplasty. | 10 | $380 | $4.5K |
| 00811 | The provider performs anesthesia services for a patient undergoing an unspecified lower intestinal endoscopic procedure where the surgical provider introduces an endoscope into the intestines up to… | 30 | $60 | $2K |
| 00731 | The anesthesia provider performs anesthesia services for an unspecified type of upper gastrointestinal endoscopic procedure during which another provider introduces the endoscope to but not beyond… | 30 | $60 | $1.9K |
| 00840 | The provider performs anesthesia services for a patient undergoing intraperitoneal procedures in the lower abdomen, including laparoscopy, which are not specified by any other anesthesia code. | 10 | $130 | $1.5K |
| 01922 | The provider performs anesthesia services for a patient undergoing non–invasive imaging or radiation therapy. | 20 | $80 | $1.3K |
| 00813 | The anesthesia provider performs anesthesia services for a patient undergoing both upper and lower intestinal endoscopy where the surgical provider introduces an endoscope into the intestines above… | 10 | $80 | $1.1K |
| 00812 | The provider performs anesthesia services for a patient undergoing a screening colonoscopy during which the surgical provider introduces an endoscope into the intestines below the duodenum, the part… | 10 | $90 | $1K |
| 00918 | The provider performs anesthesia services for a patient undergoing fragmentation, manipulation, and/or removal of a ureteral calculus. The surgical provider accesses the ureter through the urethra,… | 10 | $70 | $960 |
| 00910 | The provider performs anesthesia services for a patient undergoing transurethral procedures including urethrocystoscopy. The surgical provider may examine the organs of the urinary system from within… | 20 | $50 | $820 |
| 01810 | The provider performs anesthesia services for a patient undergoing any procedures on the nerves, muscles, tendons, fascia, and bursae of the forearm, wrist, and hand. | 10 | $50 | $760 |
Showing 1–10 of 12
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 170 | $60 | $9.6K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 80 | $50 | $4.2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 70 | $30 | $2.1K |
How this provider's Medicaid billing volume and revenue compare to other Rhode Island providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Rhode Island median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 40 | 110 | 70 | $70 | $157.8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 29 | 60 | 70 | $20 | $50.9K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 42 | 80 | 90 | $60 | $26.6K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.